Molecular Imaging: Page 3

GEHC’s MINItrace Magni cyclotron gets CE Mark

By AuntMinnie.com staff writers

MINItrace Magni is designed for in-house production of F-18, carbon-11, oxygen-15, and nitrogen-13 for PET tracers.

October 15, 2026

Lu-177 PNT2002 before SBRT extends disease control in prostate cancer

By Will Morton

A group from the University of California, Los Angeles, updated an analysis of outcomes from the LUNAR trial by 10 months.

October 13, 2026

Eckert & Ziegler Brazil signs Tb-161 supply deal with TerThera

By AuntMinnieEurope.com staff writers

TerThera will provide non-carrier-added Tb-161 to Eckert & Ziegler Brazil.

October 13, 2026

Nuclidium images first patient in phase II trial of Cu-61 PSMA tracer

By AuntMinnieEurope.com staff writers

The trial will enroll nearly three dozen patients with biopsy-confirmed metastatic prostate cancer at U.S. sites.

October 6, 2026

Mevion to install proton therapy system in Istanbul

By AuntMinnieEurope.com staff writers

The installation will establish the first proton therapy program in Türkiye's private healthcare sector.

September 29, 2026

European Nuclear Medicine Day to tackle access gaps across Europe

By Claudia Tschabuschnig

EANM and Nuclear Medicine Europe will bring policymakers, clinicians, industry, and patients together in Brussels on 29 September to push for more equitable access to nuclear medicine across Europe.

September 25, 2026

SPECT/CT holds ground as PET advances cardiac amyloidosis imaging

By Claudia Tschabuschnig

Experts discussed how SPECT/CT remains central to ATTR cardiac amyloidosis diagnosis, while emerging PET tracers could allow more direct imaging of amyloid deposits.

September 22, 2026

Telix signs agreement to acquire ITM

By Erik L. Ridley

The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.

September 21, 2026

Sustainability in cancer care: from machines to systems

By Claudia Tschabuschnig

Speakers at a session at the IAEA Scientific Forum asked what remains after the machine has been installed.

September 21, 2026

IAEA Scientific Forum: Can automated planning shorten radiotherapy waits?

By Claudia Tschabuschnig

Research promising one-second treatment planning prompted discussion of workforce shortages and delays in cancer care at the IAEA Scientific Forum in Vienna.

September 17, 2026

Radiation medicine aims to tackle cancer care inequalities in low-income countries

By Claudia Tschabuschnig

Health experts discussed challenges facing cancer care in low income countries, the potential of theranostics as well as AI, covering various topics to bridge global health disparities at the IAEA Scientific Forum in Vienna.

September 16, 2026

IAEA Scientific Forum: Where you live should not determine access to cancer care

By Claudia Tschabuschnig

At the IAEA Scientific Forum in Vienna, politicians, health policymakers, ministers, and physicians came with a bunch of numbers on the stark differences in access to radiotherapy, nuclear medicine, and medical imaging, especially in low and middle income countries.

September 15, 2026

Previous Page

Page 3 of 132

Next Page